Multimodal multicentre investigation of diagnostic and prognostic markers in disorders of consciousness.

Journal: Brain : a journal of neurology
Published Date:

Abstract

Severely brain-injured patients may enter a spectrum of conditions collectively known as disorders of consciousness. This spectrum includes clinical conditions such as unresponsive wakefulness syndrome or minimally conscious state, where the behavioural assessment of consciousness can often be deceptive. To bridge this dissociation, neuroimaging techniques are employed to identify the residual brain functions. Each neuroimaging modality imperfectly captures distinct aspects of brain preservation-functional, anatomical, or both. In this study, we adopt a comprehensive approach by integrating the neurophysiology and neuroimaging modalities available from the standard and advanced clinical assessments through interpretable machine learning. The electrophysiological modalities included high-density EEG (resting state and task), whereas neuroimaging modalities included anatomical and resting-state functional MRI, diffusion MRI and 18F-fluorodeoxyglucose PET. Our investigation reveals that specific modalities, such as functional assessments, provide comprehensive insights into the currently evaluated state of consciousness, the diagnosis of the patients. Conversely, structural modalities offer valuable information about the patient's evolution within the consciousness spectrum. We validate the proposed analysis with data coming from other centres with different acquisition parameters. Importantly, we demonstrate that model performance improves with an increase in the number of modalities. We observe a higher inter-modality disagreement for minimally conscious state patients and those patients who improve. Lastly, we observe a difference in feature importances between diagnosis and prognosis, with an interaction between modality and anatomical structures: some subcortical markers tend to contribute more to prognosis, while other cortical markers are more informative for diagnosis. This integrative multimodal and machine learning methodology presents a promising avenue for a more nuanced understanding of disorders of consciousness, contributing to enhanced diagnostic precision, prognostic capabilities and the personalization of rehabilitative strategies in clinical practice.

Authors

  • Dragana Manasova
    Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Sorbonne Université, Paris 75013, France.
  • Laouen Mayal Louan Belloli
    Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Sorbonne Université, Paris 75013, France.
  • Martin Justinus Rosenfelder
    Department of Neurology, University Hospital of the Ludwig-Maximilians-Universität München, Munich 82152, Germany.
  • Lina Willacker
    Department of Neurology, University Hospital of the Ludwig-Maximilians-Universität München, Munich 82152, Germany.
  • Emilia Fló Rama
    Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Sorbonne Université, Paris 75013, France.
  • Chiara Valota
    Department of Biomedical and Clinical Sciences, University of Milano, Milan 20157, Italy.
  • Bertrand Hermann
    Inserm 1266, Institute of Psychiatry and Neurosciences of Paris, Université Paris Cité, Paris F-75014, France.
  • Brigitte Charlotte Kaufmann
    Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Sorbonne Université, Paris 75013, France.
  • Alice Pirastru
    IRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan 20148, Italy.
  • Chiara Camilla Derchi
    IRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan 20148, Italy.
  • Theresa Raiser
    German Center for Vertigo and Balance Disorders (DSGZ), Feodor-Lynen-Str. 19, 81377 Munich, Germany; Graduate School of Systemic Neurosciences, Ludwig-Maximilians Universität München, Großhadern Str. 2, 82152 Planegg, Germany.
  • Melanie Valente
    Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Sorbonne Université, Paris 75013, France.
  • Aude Sangare
    Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Sorbonne Université, Paris 75013, France.
  • Başak Türker
    Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Sorbonne Université, Paris 75013, France.
  • Nadya Pyatigorskaya
    Center for NeuroImaging Research (CENIR), Paris Brain Institute-ICM, Paris, France.
  • Benoît Béranger
    Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Sorbonne Université, Paris 75013, France.
  • Michele Colombo
    Department of Biomedical and Clinical Sciences, University of Milano, Milan 20157, Italy.
  • Esteban Munoz-Musat
    Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Sorbonne Université, Paris 75013, France.
  • Anira Escrichs
    Computational Neuroscience Group, Center for Brain and Cognition, Department of Information and Communication Technologies, Universitat Pompeu Fabra, Barcelona, Spain.
  • Tiziana Atzori
    IRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan 20148, Italy.
  • Francesca Baglio
    IRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan 20148, Italy.
  • Constantin Lapa
    Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany. Electronic address: [email protected].
  • Ansgar Berlis
    Diagnostic and Interventional Neuroradiology, Faculty of Medicine, University of Augsburg, Augsburg 86156, Germany.
  • Kristina Krüger
    Diagnostic and Interventional Neuroradiology, Faculty of Medicine, University of Augsburg, Augsburg 86156, Germany.
  • Tina Luther
    Department of Neurology, University Hospital of the Ludwig-Maximilians-Universität München, Munich 82152, Germany.
  • Vincent Perlbarg
    BRAINTALE SAS, Paris 75013, France.
  • Gustavo Deco
    Universitat Pompeu Fabra, Theoretical and Computational Neuroscience, Barcelona, Spain; Institucio Catalana de Recerca i Estudis Avancats (ICREA), Spain.
  • Yonathan Sanz-Perl
    Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Sorbonne Université, Paris 75013, France.
  • Enzo Tagliazucchi
    Departamento de Física, Universidad de Buenos Aires and Instituto de Física de Buenos Aires (IFIBA - CONICET), Pabellón I, Ciudad Universitaria (1428), Buenos Aires, Argentina.
  • Louis Puybasset
    BRAINTALE SAS, Paris 75013, France.
  • Benjamin Rohaut
    From the Departments of Neurology (J.C., K.D., A.M., C.C., K.M.B., A.V., J.U.O., S.P., S.A., D.R., M.M., A.E., B.R.) and Neurosurgery (E.S.C.), Columbia University, and the Department of Psychology, New York University (J.-R.K.) - both in New York.
  • Lionel Naccache
    Institut du Cerveau, ICM, Inserm U 1127, CNRS UMR 7225, Sorbonne Université, F75013, Paris, France; AP-HP, Groupe hospitalier Pitié-Salpêtrière, Department of Neurophysiology, Paris, F-75013, France.
  • Angela Comanducci
    IRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan 20148, Italy.
  • Anat Arzi
    Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Sorbonne Université, Paris 75013, France.
  • Mario Rosanova
    Department of Biomedical and Clinical Sciences "L. Sacco", University of Milan, Milan, Italy.
  • Andreas Bender
    Centre for Molecular Informatics, Yusuf Hamied Department of Chemistry, University of Cambridge UK [email protected].
  • Jacobo Diego Sitt
    Institut du Cerveau, ICM, Inserm U 1127, CNRS UMR 7225, Sorbonne Université, F75013, Paris, France; Cognitive Neuroimaging Unit, Institut National de la Santé et de la Recherche Médicale, U992, F-91191 Gif/Yvette, France; NeuroSpin Centre, Institute of BioImaging Commissariat à l'Energie Atomique, F-91191 Gif/Yvette, France.

Keywords

No keywords available for this article.